Simultaneous Symposia 1b: Hepatitis C: The Future Has Arrived
Monday October, 20
11:30 am – 12:45 pm
Moderator: Stanley M. Cohen, MD

Evaluating Your Patient for Therapy Using All Oral Therapies
Stanley M. Cohen, MD
Use elastography to identify patients with hepatitis C (including fibrosis assessment).

Genotype 1 Treatment Options
Mitchell L. Shiffman, MD, FACG
Apply recent phase 3 treatment options for genotype 1 infected individuals who are treatment naïve and non-responders to previous therapy.

Genotype 2/3 Other Populations
Andrew J. Muir, MD, MHS
Apply treatment options for genotype 2/3 infected individuals including nonresponding genotype 3 cirrhotic patients, implement treatment strategies in special populations including those who are (a) HCV/HIV infected and (b) awaiting liver transplant, and explain post-transplant outcomes.